Vision By Design 2026

October 21, 2026 to October 24, 2026

Vision by Design is an annual conference where the global myopia community gathers to learn, connect, and shape the future of care. Four intensive days of clinical education, emerging research, and real-world strategy.

Target Audience

This educational activity is designed for optometrists and ophthalmologists who wish to expand their knowledge and clinical competence in myopia management. The program is appropriate for eye care professionals who are new to myopia management as well as practitioners seeking to enhance their understanding of current evidence-based treatment strategies.

Learning Objectives

  • Describe the epidemiology and public health impact of childhood myopia and progressive myopia.
  • Identify patients at risk for developing or progressing myopia through appropriate clinical evaluation and risk assessment.
  • Compare current evidence-based myopia management treatment options, including: Orthokeratology Soft multifocal/myopia control contact lenses Low-dose atropine therapy Combination treatment approaches Explain treatment selection criteria, implementation protocols, and monitoring strategies for each modality.
  • Discuss practical approaches for incorporating myopia management services into clinical practice.

Course summary

Course opens: 
08/24/2026
Course expires: 
10/24/2026
Event starts: 
10/21/2026 - 7:00am EDT
Event ends: 
10/24/2026 - 11:59pm EDT
Cost:
$0.00
Rating: 
0
Cleveland, OH
United States
Speaker, Instructor, Faculty(s)

Thomas Aller, OD, FBCLA

has a financial relationship (Advisor) with Zeiss;.
has a financial relationship (Consultant) with Euclid Vision;.
has a financial relationship (Consultant) with BHVI;.
has a financial relationship (Individual stocks and stock options) with TreeHouse Eyes;.
has a financial relationship (Royalties or patent beneficiary) with Myopia Care (Eyetific);.
has a financial relationship (Royalties or patent beneficiary) with BHVI;.
has a financial relationship (Individual stocks and stock options) with Reopia Optics, Inc.;.
has a financial relationship (Advisor) with Reopia Optics, Inc;.

Dwight Barnes, O.D., FIAOMC, IAMCC

has no relevant financial relationships to disclose at this time.

Zhi Chen

has no relevant financial relationships to disclose at this time.

Jagrut Lallu, MSc Specialty Lenses (Hons), BOptom (Hons)

has no relevant financial relationships to disclose at this time.

Paul Levine, OD, FIAOMC, FAAO, IACMM

has no relevant financial relationships to disclose at this time.

xinjie mao

has no relevant financial relationships to disclose at this time.

Jennifer Qayum, OD

has no relevant financial relationships to disclose at this time.

Patrick Simard, OD, MSc, MBA, FAAO, Dipl AAO, FBCLA, FIACLE, FIAOMC, IACMM

has a financial relationship (Speaker) with Eaglett Eye;.
has a financial relationship (Royalties or patent beneficiary) with Bausch and Lomb;.
has a financial relationship (Researcher) with EssilorLuxottica;.
has a financial relationship (Researcher) with Zilia;.
has a financial relationship (Researcher) with Contamac;.
has a financial relationship (Researcher) with Labtician;.
has a financial relationship (Speaker) with Wave Contact Lenses ;.
has a financial relationship (Consultant) with Sun Pharma;.
has a financial relationship (Consultant) with Nordic Pharma;.
has a financial relationship (Speaker) with Oculus;.

Jonathan Skoner, OD, FIAOMC, IACMM

has a financial relationship (Consultant) with Bausch and Lomb;.

Sherman Tung

has a financial relationship (Speaker) with Hoya;.
has a financial relationship (Speaker) with 3N ;.
has a financial relationship (Speaker) with Topcon;.

Tze Yu Tung, OD

has a financial relationship (Executive role) with Shinyeyes Corp;.

Christina Twardowski, OD, FAAO

has no relevant financial relationships to disclose at this time.

Jeffrey Walline, OD PhD

has no relevant financial relationships to disclose at this time.

Thomas Weshefsky, OD, FIAOMC

has no relevant financial relationships to disclose at this time.

Laurence Wong, OD

has no relevant financial relationships to disclose at this time.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and [node:field-custom-joint-provider]. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


This activity was planned by and for the healthcare team, and learners will receive XX Interprofessional Continuing Education (IPCE) credit for learning and change.

Price

Cost:
$0.00
Please login or register to take this course.